Discovery of green tea polyphenol-based proteasome inhibitors - A successful collaboration with Tak-Hang (Bill) Chan

This article is written to commemorate the contributions of Professor Tak-Hang (Bill) Chan to the field of chem- istry and his collaborative efforts that have lead to insights pertaining to cancer cell biology and the development of poten- tial cancer therapeutic agents. This article reviews the chronological scientific findings that evolved from a partnership between Bill Chan and Q. Ping Dou, spanning more than 10 years. While many compounds have been chemically synthe- sized by the Chan group and biologically scrutinized by the Dou group, the outcomes presented here will focus on green tea polyphenols as tumor proteasome inhibitors and anticancer agents. Furthermore, the biochemical alterations that increase or decrease the therapeutic potential of the polyphenol compounds in human cancer cells will also be discussed.

[1]  Guo Wang,et al.  The syntheses and characterizations of vanadium complexes with 1,2-dihydroxyanthraquinone and the structure-effect relationship in their in vitro anticancer activities. , 2013, Dalton transactions.

[2]  Guo Wang,et al.  The syntheses and characterizations of molybdenum(VI) complexes with catechol and 2,3-dihydroxynaphthalene, and the structure-effect relationship in their in vitro anticancer activities. , 2012, Dalton transactions.

[3]  Di Chen,et al.  Inhibition of catechol-O-methyltransferase activity in human breast cancer cells enhances the biological effect of the green tea polyphenol (-)-EGCG , 2010 .

[4]  T. Chan,et al.  Computational modeling of the potential interactions of the proteasome beta5 subunit and catechol-O-methyltransferase-resistant EGCG analogs. , 2010, International journal of molecular medicine.

[5]  T. Chan,et al.  Proteasome inhibition in human breast cancer cells with high catechol-O-methyltransferase activity by green tea polyphenol EGCG analogs. , 2010, Bioorganic & medicinal chemistry.

[6]  D. Kuhn,et al.  Methylation suppresses the proteasome‐inhibitory function of green tea polyphenols , 2007, Journal of cellular physiology.

[7]  K. Landis-Piwowar,et al.  A para-amino substituent on the D-ring of green tea polyphenol epigallocatechin-3-gallate as a novel proteasome inhibitor and cancer cell apoptosis inducer. , 2007, Bioorganic & medicinal chemistry.

[8]  Di Chen,et al.  A novel prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate as a potential anticancer agent. , 2007, Cancer research.

[9]  Di Chen,et al.  The proteasome as a potential target for novel anticancer drugs and chemosensitizers. , 2006, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[10]  Di Chen,et al.  Methylation of green tea polyphenols affects their binding to and inhibitory poses of the proteasome beta5 subunit. , 2006, International journal of molecular medicine.

[11]  D. Chauhan,et al.  Perspectives for combination therapy to overcome drug-resistant multiple myeloma. , 2005, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[12]  L. Chow,et al.  Synthetic peracetate tea polyphenols as potent proteasome inhibitors and apoptosis inducers in human cancer cells. , 2005, Frontiers in bioscience : a journal and virtual library.

[13]  Di Chen,et al.  Evaluation of proteasome-inhibitory and apoptosis-inducing potencies of novel (-)-EGCG analogs and their prodrugs. , 2005, International journal of molecular medicine.

[14]  Di Chen,et al.  Structure-activity study of epi-gallocatechin gallate (EGCG) analogs as proteasome inhibitors. , 2005, Bioorganic & medicinal chemistry.

[15]  Michael L. Wang,et al.  Phase II study of proteasome inhibitor bortezomib in relapsed or refractory B-cell non-Hodgkin's lymphoma. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  P. Richardson,et al.  Proteasome Inhibition in the Treatment of Cancer , 2005, Cell cycle.

[17]  A. Chan,et al.  A potential prodrug for a green tea polyphenol proteasome inhibitor: evaluation of the peracetate ester of (-)-epigallocatechin gallate [(-)-EGCG]. , 2004, Bioorganic & medicinal chemistry.

[18]  Di Chen,et al.  Study of the green tea polyphenols catechin-3-gallate (CG) and epicatechin-3-gallate (ECG) as proteasome inhibitors. , 2004, Bioorganic & medicinal chemistry.

[19]  Naveen Kumar,et al.  Structure-activity relationships of synthetic analogs of (-)-epigallocatechin-3-gallate as proteasome inhibitors. , 2004, Anticancer research.

[20]  W. Guida,et al.  Docking studies and model development of tea polyphenol proteasome inhibitors: Applications to rational drug design , 2003, Proteins.

[21]  Xiaofeng Meng,et al.  Enzymology of methylation of tea catechins and inhibition of catechol-O-methyltransferase by (-)-epigallocatechin gallate. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[22]  Q. Dou,et al.  Synthetic Analogs of Green Tea Polyphenols as Proteasome Inhibitors , 2002, Molecular medicine.

[23]  David M. Smith,et al.  Ester Bond-containing Tea Polyphenols Potently Inhibit Proteasome Activity in Vitro and in Vivo * , 2001, The Journal of Biological Chemistry.

[24]  T. Chan,et al.  Enantioselective synthesis of epigallocatechin-3-gallate (EGCG), the active polyphenol component from green tea. , 2001, Organic letters.

[25]  F. Nanjo,et al.  Methylation of tea catechins by rat liver homogenates. , 1999, Bioscience, biotechnology, and biochemistry.

[26]  Yu Huang,et al.  Stability of Green Tea Catechins , 1997 .

[27]  Yu Huang,et al.  Degradation of green tea catechins in tea drinks. , 2001, Journal of agricultural and food chemistry.